Exjade and Thinking abnormal - a phase IV clinical study of FDA data

Among these 13 people:

How long have people been on Exjade when they have Thinking abnormal? *

• < 1 month: 11.11 %
• 1 - 6 months: 0.0 %
• 6 - 12 months: 0.0 %
• 1 - 2 years: 88.89 %
• 2 - 5 years: 0.0 %
• 5 - 10 years: 0.0 %
• 10+ years: 0.0 %

What is the gender of people who have Thinking abnormal when taking Exjade? *

• female: 83.33 %
• male: 16.67 %

What is the age of people who have Thinking abnormal when taking Exjade? *

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 50 %
• 20-29: 0.0 %
• 30-39: 0.0 %
• 40-49: 0.0 %
• 50-59: 0.0 %
• 60+: 50 %

What are other drugs people take besides Exjade? *

1. Desferal: 9 people, 69.23%
2. Prevacid: 8 people, 61.54%
3. Jadenu: 8 people, 61.54%
4. Seroquel: 2 people, 15.38%
5. Vitamin B6: 1 person, 7.69%
6. Soma: 1 person, 7.69%
7. Ritalin: 1 person, 7.69%
8. Pristiq: 1 person, 7.69%
9. Pravachol: 1 person, 7.69%
10. Lyrica: 1 person, 7.69%

What are other side effects people have besides Thinking abnormal? *

1. Nausea And Vomiting: 10 people, 76.92%
2. Drug Ineffective: 9 people, 69.23%
3. Haemoglobin Decreased: 9 people, 69.23%
4. Thrombocytopenia (decrease of platelets in blood): 9 people, 69.23%
5. Feeling Abnormal: 9 people, 69.23%
6. Serum Ferritin Increased: 9 people, 69.23%
7. Nausea (feeling of having an urge to vomit): 9 people, 69.23%
8. Constipation: 8 people, 61.54%
9. Diarrhea: 8 people, 61.54%
10. Depression: 8 people, 61.54%

What are the existing conditions these people have? *

1. Primary Myelofibrosis (primary disorder of the bone marrow): 8 people, 61.54%
2. Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 7.69%
3. Suicidal Ideation: 1 person, 7.69%
4. Stress And Anxiety: 1 person, 7.69%
5. Nightmares (unpleasant dreams): 1 person, 7.69%
6. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 7.69%
7. Iron Deficiency: 1 person, 7.69%
8. Inflammation: 1 person, 7.69%
9. High Blood Cholesterol: 1 person, 7.69%
10. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.69%

Do you take Exjade and have Thinking abnormal?

- Check whether Thinking abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

---

---

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exjade:

Thinking abnormal treatments and more:

How severe was Thinking abnormal and when was it recovered:

• Thinking abnormal in Exjade

Expand to all the drugs that have ingredients of deferasirox:

• Thinking abnormal and drugs with ingredients of deferasirox

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

• Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
• Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
• Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
• Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
• Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
• Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
• Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
• Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
• Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
• Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .

---

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Exjade) and Exjade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

---

---

Recent studies on eHealthMe:

• Drug interactions of Entocort Ec and Valium - 3 seconds ago
• Concerta and Neutropenia for Women aged 60+ - 6 seconds ago
• Concerta and Granulopenia for Women aged 60+ - 6 seconds ago
• Concerta and Granulocytopenia for Women aged 60+ - 6 seconds ago
• Concerta and Agranulocytosis for Women aged 60+ - 7 seconds ago
• Anastrozole and Nonspecific Back Pain for Women aged 50-59 - 7 seconds ago
• Anastrozole and Pain - Back for Women aged 50-59 - 7 seconds ago
• Anastrozole and Back Pain - Nonspecific for Women aged 50-59 - 8 seconds ago
• Anastrozole and Back Pain for Women aged 50-59 - 8 seconds ago
• Could Apixaban cause Cerebral Disorder? - 11 seconds ago